08 September 2020 : Clinical Research
Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation
Zefeng Wang1ACDE, Liting Cheng1BCD, Junmeng Zhang1AD, Zhuo Liang1CD, Ruiqing Dong2B, Fei Hang1B, Xinlu Wang1B, Ziyu Wang1B, Yongquan Wu1AD*, Jie Du3ADEDOI: 10.12659/MSM.926221
Med Sci Monit 2020; 26:e926221
Table 2 Comparison of primary outcomes.
| Group A (n=125) | Group B (n=52) | P valve | |
|---|---|---|---|
| TIMP-1 | 82.2±24.1 | 84.4±27.9 | 0.612 |
| Log10(GDF-15), ng/ml | 3.0±0.1 | 3.0±0.1 | 0.215 |
| sST2, ng/ml | 23.9±3.3 | 30.9±5.0 | 0.000 |
| Normally distributed continuous variables are expressed as mean ± standard deviation; non-uniformly distributed data are expressed as median (Q1, Q3). Hs CRP – high-sensitive C-reactive protein; sST2 – soluble ST2; GDF-15 – growth differentiation factor 15. | |||